Abu T. Serajuddin, Ph.D.

Professor
Pharmaceutical Sciences
St. John's University, Ph.D., Industrial PharmacyColumbia University, MS, PharmaceuticsDhaka University (Bangladesh), B Pharm., (Honors)

Abu Serajuddin, Ph.D, joined St. John’s University in September 2008 as Professor of Industrial Pharmacy after working for 32 years in major multi-national pharmaceutical companies in scientific and managerial positions. In his latest positions in the industry, he worked for Novartis Pharmaceuticals Corp. as Director (1999-2002) and Executive Director (2002-2003) for drug product development in the US (Department Head, Pharmaceutical R&D) and then as Executive Director of Science, Technology & Outsourcing (2003-2008) with global responsibilities of developing drug delivery and pharmaceutical processing technologies and the management of science and technology initiatives (Head, Science & Technology Forum). Prior to joining Novartis, he worked in Pharmaceutical R&D in Bristol-Myers Squibb (1986-1999) and Revlon Health Care Group (1976-1986); the later became Sanofi-Aventis through mergers. Novartis named him Novartis Leading Scientist (2005) for extraordinary scientific excellence, and Bristol-Myers Squibb bestowed him President’s Award unprecedented 3 times (1996-1998) for outstanding contribution to drug development.

At St. John’s University, Dr. Serajuddin has built a world-class teaching and research program for development of drug delivery systems and pharmaceutical processing technologies. He helped the University in establishing the Industrial Pharmaceutical Innovation Laboratory for advanced research in pharmaceutical technologies. His contributions have been recognized by St. John’s with the Faculty Recognition Award for Outstanding Teaching and Services consecutively 10 times (2009-2018), College of Pharmacy and Health Sciences Distinguished Alumni Award (2018), and the University Medal for Outstanding Achievement (2019).

He authored over 100 research papers and book chapters, and he is a co-inventor in 13 issued patents. As of May 2019, his publications have received over 8000 citations in the pharmaceutical literature. He made 140 invited presentations in major scientific conferences and meetings in the USA and abroad (France, Croatia, Japan, China, and Taiwan).

For his scientific and professional achievements, Dr. Serajuddin was elected Fellow of American Association of Pharmaceutical Scientists (AAPS) and American Pharmacists Association (APhA). AAPS also bestowed him three of its most distinguished awards: AAPS Research Achievement Award for Formulation Design and Development (2010), AAPS Research Achievement Award for Manufacturing Science and Engineering (2014), and AAPS Lipid-Based Drug Delivery Outstanding Research Award (2015). He was the recipient of the IPEC Ralph Shangraw Memorial Award (2016), the highest scientific recognition given by the International Pharmaceutical Excipients Council (IPEC). He held numerous leadership positions in professional organizations. Currently, he serves in Editorial Advisory Boards of Journal of Pharmaceutical Sciences and Journal of Excipients and Food Chemicals.

The primary mission of the Industrial Pharmacy Program at St. John’s University is to educate and train students to address drug product development needs of pharmaceutical companies in the USA, the majority of which are located in the northeast region of the USA within 200 miles of the university. It is one of the only two such Industrial Pharmacy programs in the USA. To meet the industry needs and develop better drug products, Prof. Abu Serajuddin has built the Industrial Pharmacy Innovation Center at St. John’s University. 

Learn More: 

Industrial Pharmacy Innovation Center
Facilities and Equipment 

 

Current research interests:

  • Bioavailability enhancement of poorly water-soluble drugs
  • Nanocrystal technology
  • Co-crystal technology
  • Lipid-based drug delivery systems
  • Solid dispersion by melt extrusion
  • Supersolubilization of drugs by acid-base interaction
  • Melt granulation
  • Continuous manufacturing of pharmaceutical dosage forms
  • 3D printing technology
  • Permeation study and toxicity testing using cell cultures

Dr. Serajuddin’s research has been supported by $1,150,000 research grants from pharmaceutical industry (ABITEC, Catalent, Hoffmann La Roche, Abon Lab, Latitude Pharma, Bristol-Myers Squibb and others) and $700,000 seed money and equipment grant from St. John’s University. In addition, he helped raise $500,000 from alumni and friends to build Industrial Pharmacy Innovation Laboratory.

Recently, Dr. Serajuddin received National Science Foundation Planning Grant (2018-19) under the IUCRC program for establishment of the NSF Center for Integrated Material Sciences and Engineering for Pharmaceutical Products (CIMSEPP), in collaboration with the University of Minnesota and New Jersey Institute of Technology (NJIT). 
 

Publications (10 years; 2009-2019, as of May 2019)

  • Vasoya, J. M., Shah, A. V., Serajuddin, A. (2019). Investigation of possible solubility and dissolution advantages of cocrystals, I: Aqueous solubility and dissolution rates of ketoconazole and its cocrystals as functions of pH. ADMET and DMPK, 7(2), 106-130.
  • Solanki, N. G., Gumaste, S. G., Shah, A. V., Serajuddin, A. T. (2019). Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot Melt Extrusion. II: Rheological Analysis and Extrudability Testing. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2019.05.010. Published online on May 16, 2019.
  • Solanki, N. G., Lam, K., Tahsin, M., Gumaste, S. G., Shah, A. V., Serajuddin, A. T. (2019). Effects of surfactants on itraconazole-HPMCAS solid dispersion prepared by hot-melt extrusion I: Miscibility and drug release. Journal of pharmaceutical sciences, 108(4), 1453-1465.
  • Marković, O. S., Pešić, M. P., Shah, A. V., Serajuddin, A. T., Verbić, T. Ž., Avdeef, A. (2019). Solubility-pH profile of desipramine hydrochloride in saline phosphate buffer: Enhanced solubility due to drug-buffer aggregates. European Journal of Pharmaceutical Sciences, 133, 264-274
  • Shah, A. V., Serajuddin, A. T. (2019). Twin Screw Continuous Wet Granulation. In Handbook of Pharmaceutical Wet Granulation (pp. 791-823). Academic Press.
  • Vasoya, J. M., Desai, H. H., Gumaste, S. G., Tillotson, J., Kelemen, D., Dalrymple, D. M., Serajuddin, A. T. (2019). Development of Solid Dispersion by Hot Melt Extrusion Using Mixtures of Polyoxylglycerides With Polymers as Carriers for Increasing Dissolution Rate of a Poorly Soluble Drug Model. Journal of pharmaceutical sciences, 108(2), 888-896.
  • Prajapati, H. N., Serajuddin, A. T. (2019). Sugar ester nanoparticle stabilizers. US Patent: US 10,166,197B2.
  • Shah, A. V., Serajuddin, A. T., Mangione, R. A. (2018). Making all medications gluten free. Journal of pharmaceutical sciences, 107(5), 1263-1268.
  • Vasanthavada, M., Gupta, S.S., Tong, W. Q. T., Serajuddin, A. T. (2018). Development of solid dispersion for poorly water-soluble drugs. In Water-insoluble drug formulation, 3rd ed., Ron Liu, ed., (pp. 541-574). CRC Press.
  • Solanki, N. G., Tahsin, M., Shah, A. V., Serajuddin, A. T. (2018). Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: screening polymers for drug release, drug-polymer miscibility and printability. Journal of pharmaceutical sciences, 107(1), 390-401.
  • Solanki, N., Gupta, S. S., Serajuddin, A. T. (2018). Rheological analysis of itraconazole-polymer mixtures to determine optimal melt extrusion temperature for development of amorphous solid dispersion. European Journal of Pharmaceutical Sciences, 111, 482-491.
  • Shah, A., Thool, P., Sorathiya, K., Prajapati, H., Dalrymple, D., Serajuddin, A. T. (2018). Effect of different polysorbates on development of self-microemulsifying drug delivery systems using medium chain lipids. Drug development and industrial pharmacy, 44(2), 215-223.
  • Shah, A. V., Desai, H. H., Thool, P., Dalrymple, D., Serajuddin, A. T. (2018). Development of self-microemulsifying drug delivery system for oral delivery of poorly water-soluble nutraceuticals. Drug development and industrial pharmacy, 44(6), 895-901.
  • Parikh, T., Serajuddin, A. T. (2018). Development of fast-dissolving amorphous solid dispersion of itraconazole by melt extrusion of its mixture with weak organic carboxylic acid and polymer. Pharmaceutical research, 35, 1-10.
  • Gumaste, S. G., Serajuddin, A. T. (2017). Development of solid SEDDS, VII: Effect of pore size of silica on drug release from adsorbed self-emulsifying lipid-based formulations. European Journal of Pharmaceutical Sciences, 110, 134-147.
  • Gumaste, S. G., Freire, B. O., Serajuddin, A. T. (2017). Development of solid SEDDS, VI: effect of precoating of Neusilin® US2 with PVP on drug release from adsorbed self-emulsifying lipid-based formulations. European Journal of Pharmaceutical Sciences, 110, 124-133.
  • Lee, H. L., Vasoya, J. M., Cirqueira, M. D. L., Yeh, K. L., Lee, T., Serajuddin, A. T. (2017). Continuous Preparation of 1: 1 Haloperidol–Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder. Molecular pharmaceutics, 14(4), 1278-1291.
  • Meena, A. K., Desai, D., Serajuddin, A. T. (2017). Development and optimization of a wet granulation process at elevated temperature for a poorly compactible drug using twin screw extruder for continuous manufacturing. Journal of pharmaceutical sciences, 106(2), 589-600.
  • Batra, A., Desai, D., Serajuddin, A. T. (2017). Investigating the use of polymeric binders in twin screw melt granulation process for improving compactibility of drugs. Journal of pharmaceutical sciences, 106(1), 140-150.
  • Bu, P., Ji, Y., Narayanan, S., Dalrymple, D., Cheng, X., Serajuddin, A. T. (2017). Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant. European Journal of Pharmaceutical Sciences, 99, 350-360.
  • Bu, P., Narayanan, S., Dalrymple, D., Cheng, X., Serajuddin, A. T. (2016). Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant. European Journal of Pharmaceutical Sciences, 91, 162-171.
  • Dickinson, P. A., Kesisoglou, F., Flanagan, T., Martinez, M. N., Mistry, H. B., Crison, J. R., Mistry, H. B., Cruañes, M. T., Martinez, M. N.,  Lennernäs, H., Wigal, T. L., Swinney, D. C., Polli, J. E., Serajuddin, A. T. M., Cook, J. A., Dressman, J. B. (2016). Optimizing clinical drug product performance: applying biopharmaceutics risk assessment roadmap (BioRAM) and the BioRAM Scoring Grid. Journal of pharmaceutical sciences, 105(11), 3243-3255.
  • Gumaste, S. G., Gupta, S. S., & Serajuddin, A. T. (2016). Investigation of polymer-surfactant and polymer-drug-surfactant miscibility for solid dispersion. The AAPS journal, 18(5), 1131-1143.
  • Parikh, T., Sandhu, H. K., Talele, T. T., Serajuddin, A. T. (2016). Characterization of solid dispersion of itraconazole prepared by solubilization in concentrated aqueous solutions of weak organic acids and drying. Pharmaceutical research, 33(6), 1456-1471.
  • Gupta, S. S., Solanki, N., Serajuddin, A. T. (2016). Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion, IV: Affinisol™ HPMC HME polymers. AAPS Pharmscitech, 17(1), 148-157.
  • Parikh, T., Gupta, S. S., Meena, A. K., Vitez, I., Mahajan, N., Serajuddin, A. T. (2015). Application of film-casting technique to investigate drug–polymer miscibility in solid dispersion and hot-melt extrudate. Journal of pharmaceutical sciences, 104(7), 2142-2152.
  • Shah, A., Serajuddin, A. T. (2015). Conversion of solid dispersion prepared by acid–base interaction into free-flowing and tabletable powder by using Neusilin® US2. International journal of pharmaceutics, 484(1-2), 172-180.
  • Gupta, S. S., Parikh, T., Meena, A. K., Mahajan, N., Vitez, I., Serajuddin, A. T. (2015). Effect of carbamazepine on viscoelastic properties and hot melt extrudability of Soluplus®. International journal of pharmaceutics, 478(1), 232-239.
  • Shah A., Serajuddin A. (2014) Supersolubilization by Using Nonsalt-Forming Acid-Base Interaction. In: Shah N., Sandhu H., Choi D., Chokshi H., Malick A. (eds) Amorphous Solid Dispersions. Advances in Delivery Science and Technology. Springer, New York, NY
  • Selen, A., Dickinson, P. A., Müllertz, A., Crison, J. R., Mistry, H. B., Cruañes, M. T., Martinez, M.N., Lennernäs, H., T. L. Wigal, Swinney, D.C., Polli, J.E.,  Serajuddin, A.T.M., Cook, J.A., Dressman, J.B. (2014). The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance. Journal of pharmaceutical sciences, 103(11), 3377-3397.
  • Parikh, T., Gupta, S. S., Meena, A., Serajuddin, A. T. (2014). Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion-III: Polymethacrylates and polymethacrylic acid based polymers. Journal of Excipients and Food Chemicals, 5(1), 56-64.
  • Meena, A., Parikh, T., Gupta, S. S., Serajuddin, A. T. (2014). Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion-II: Cellulosic polymers. Journal of Excipients and Food Chemicals, 5(1), 46-55.
  • Gupta, S. S., Meena, A., Parikh, T., Serajuddin, A. T. (2014). Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion-I: Polyvinylpyrrolidone and related polymers. Journal of Excipients and Food Chemicals, 5(1), 32-45.
  • Serajuddin, A. T. (2014). The future of tableting technology. Journal of Excipients and Food Chemicals, 5(1), 1-4
  • Prajapati, H. N., Dalrymple, D. M., Serajuddin, A. T. (2013). In vitro dispersion test that could serve as a predictive method for assessing performance of lipid-based drug delivery systems. Journal of Excipients and Food Chemicals, 4(4), 111-125.
  • Gumaste, S. G., Dalrymple, D. M., Serajuddin, A. T. (2013). Development of solid SEDDS, V: compaction and drug release properties of tablets prepared by adsorbing lipid-based formulations onto Neusilin® US2. Pharmaceutical research, 30(12), 3186-3199.
  • Gumaste, S. G., Pawlak, S. A., Dalrymple, D. M., Nider, C. J., Trombetta, L. D., Serajuddin, A. T. (2013). Development of solid SEDDS, IV: effect of adsorbed lipid and surfactant on tableting properties and surface structures of different silicates. Pharmaceutical research, 30(12), 3170-3185.
  • Singh, S., Parikh, T., Sandhu, H. K., Shah, N. H., Malick, A. W., Singhal, D., Serajuddin, A. T. (2013). Supersolubilization and amorphization of a model basic drug, haloperidol, by interaction with weak acids. Pharmaceutical research, 30(6), 1561-1573.
  • Patel, D. P., Li, P., Serajuddin, A. T. (2012). Enhanced microemulsion formation in lipid-based drug delivery systems by combining mono-esters of medium chain fatty acids with di-or tri-esters. Journal of Excipients and Food Chemicals, 3(2), 29-44.
  • Patel, N., Dalrymple, D. M., Serajuddin, A. T. (2012). Development of solid SEDDS, III: Application of Acconon® C-50 and Gelucire® 50/13 as both solidifying and emulsifying agents for medium chain triglycerides. Journal of Excipients and Food Chemicals, 3(2), 83-92.
  • Patel, N., Prajapati, H. N., Dalrymple, D. M., Serajuddin, A. T. (2012). Development of Solid SEDDS, II: application of Acconon® C-44 and Gelucire® 44/14 as solidifying agents for self-emulsifying drug delivery systems of medium chain triglyceride. Journal of Excipients and Food Chemicals, 3(2), 54-66.
  • Shah, A. V., Serajuddin, A. T. (2012). Development of solid self-emulsifying drug delivery system (SEDDS) I: Use of poloxamer 188 as both solidifying and emulsifying agent for lipids. Pharmaceutical research, 29(10), 2817-2832.
  • Prajapati, H. N., Dalrymple, D. M., Serajuddin, A. T. (2012). A comparative evaluation of mono-, di-and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development. Pharmaceutical research, 29(1), 285-305.
  • Vasanthavada, M., Lakshman, J., Tong, W. Q., Serajuddin, A. T., Joshi, Y., & Kowalski, J. (2012). Process for making compositions with poorly compressible therapeutic compounds. U.S. Patent Application No. 13/307,864.
  • Prajapati, H. N., Patel, D. P., Patel, N. G., Dalrymple, D. D., Serajuddin, A. T. (2011). Effect of difference in fatty acid chain lengths of medium-chain lipids on lipid-surfactant-water phase diagrams and drug solubility. Journal of Excipients and Food Chemicals, 2(3), 73-88.
  • Vasanthavada, M., Wang, Y., Haefele, T., Lakshman, J. P., Mone, M., Tong, W., Serajuddin, A. T. (2011). Application of melt granulation technology using twin-screw extruder in development of high-dose modified-release tablet formulation. Journal of pharmaceutical sciences, 100(5), 1923-1934.
  • Lakshman, J. P., Kowalski, J., Vasanthavada, M., Tong, W. Q., Joshi, Y. M., Serajuddin, A. T. (2011). Application of melt granulation technology to enhance tabletting properties of poorly compactible high‐dose drugs. Journal of pharmaceutical sciences, 100(4), 1553-1565.
  • Kowalski, J., Lakshman, J. P., Serajuddin, A. T., Tong, W. Q., Vasanthavada, M. (2011). Continuous process for making pharmaceutical compositions. U.S. Patent Application No. 12/990,151.
  • Kowalski, J., Lakshman, J. P., Serajuddin, A. T., Joshi, Y. (2010). Modified Release 1-[(3-Hydroxy-Adamant-1-Ylamino)-Acetyl]-Pyrrolidine-2 (S)-Carbonitrile Formulation. U.S. Patent Application No. 11/916,931.
  • Li, P., Hynes, S. R., Haefele, T. F., Pudipeddi, M., Royce, A. E., Serajuddin, A. T. (2009). Development of clinical dosage forms for a poorly water‐soluble drug II: Formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water‐soluble drug. Journal of pharmaceutical sciences, 98(5), 1750-1764.
  • Kowalski, J., Kalb, O., Joshi, Y. M., Serajuddin, A. T. (2009). Application of melt granulation technology to enhance stability of a moisture sensitive immediate-release drug product. International journal of pharmaceutics, 381(1), 56-61.
  • Kowalski, J., Lakshman, J. P., Serajuddin, A. T., Tong, W. Q. (2009). Heated roller compaction process for making pharmaceutical compositions. U.S. Patent Application No. 12/299,036.

Invited Presentations (5 years; 2014-2019, as of May 2019)

  • Enabling strategies for development of HPMCAS-based amorphous solid dispersion by HME. Webinar, sponsored by Thermo Fisher Scientific (Available on demand: https://www.thermofisher.com/solubilitywebinars), April 23, 2019.
  • Development of HPMCAS-based solid dispersion and modified release dosage form by using the hot melt extrusion technology. AAPS Northeast Regional Discussion Group (NERDG) Annual Meeting, Farmington, CT.  April 11, 2019.
  • A toolbox to enhance drug performance: Formulation of 3D-printed tablets for rapid drug release by fused deposition. AAPS Annual Meeting (AAPS PhrmSci 360), Washington, DC. November 6, 2018.
  • Bioavailability enhancing technologies for poorly water-soluble drugs. Short course presentation at IAPC (International Association of Physical Chemists) 7th World Conference on Physicochemical Methods Applied to Drug Discovery and Development, Osaka, Japan. August 27, 2018.
  • Development of supersaturating solid dispersions of poorly water-soluble basic drugs by interaction with non-salt forming weak carboxylic acids and with HPMC-AS. IAPC (International Association of Physical Chemists) 7th World Conference on Physicochemical Methods Applied to Drug Discovery and Development, Osaka, Japan. August 30, 2018.
  • Formulation of 3D printed tablets for rapid drug release by fused deposition modeling. Controlled Release Society (CRS) Annual Meeting, New York, NY. July 24-28, 2018.
  • Application of hot melt extrusion technology in development of solid dispersion systems for poorly water-soluble drugs. Advances in Drug Delivery Conference, Touro College, New York. May 24, 2018.
  • Investigation of HPMCAS-surfactant and hpmcas-drug-surfactant miscibility for solid dispersion, hot melt extrusion and drug release. The American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, San Diego, California. November, 2017.
  • Biopharmaceutical roadmap: Optimization of clinical drug product performance. 3rd International Summer School on Drug Development at 6th World Conference on Physicochemical Methods Applied to Drug Discovery and Development organized by International Association of Physical Chemists, Zagreb, Croatia.  September 1-3, 2017.
  • Recent advances in the solid dispersions of poorly water-soluble drugs. 3rd International Summer School on Drug Development at 6th World Conference on Physicochemical Methods Applied to Drug Discovery and Development organized by International Association of Physical Chemists, Zagreb, Croatia.  September 1-3, 2017.
  • Strategies for the development of liquid, semisolid and solid lipid-based drug delivery systems.  Sixth World Conference on Physicochemical Methods in Drug Discovery and Development, Zagreb, Croatia.  September 4-7, 2017.
  • How feasible is it to form cocrystals by acid-base interaction?  Sixth World Conference on Physicochemical Methods in Drug Discovery and Development, Zagreb, Croatia. September 4-7, 2017.
  • Quality formulation for success: Development of products according to biopharmaceutical risk assessment roadmap. The Fourth Annual American Association of Bangladeshi Pharmaceutical Scientists (AABPS) Convention, Marriott Courtyard-University of Delaware, Newark, Delaware. July 21-22, 2017.
  • Advances in small molecule drug delivery: Solid dispersion by acid-base interaction and supersolubilization. The 20th Annual AAPS Northeast Regional Discussion Group (NERDG) Meeting, Farmington, Connecticut. April 20, 2017.
  • How integration of excipient science with technology can lead to better products and continuous manufacturing. Ralph Shangraw Memorial Lecture, Excipients Focus Group Town Hall Meeting at AAPS Annual Meeting, Denver, Colorado.  November 13-17, 2016.
  • Investigation of HPMCAS-surfactant and hpmcas-drug-surfactant miscibility for solid dispersion and hot melt extrusion. Second Annual Shinetsu Conference on “Recent Advances in Drug Delivery and Solubility Enhancement Based on Cellulosic Polymers”, Cambridge, Massachusetts. September 14, 2016.
  • Transforming new molecular entities into drug products.  Fifth World Conference on Physicochemical Methods in Drug Discovery and Development, Zhuhai, China. August 23-26, 2016.
  • Optimization of clinical drug product performance using biopharmaceutics risk assessment roadmap (BioRAM).  Fifth World Conference on Physicochemical Methods in Drug Discovery and Development, Zhuhai, China. August 23-26, 2016.
  • Strategies for the development of liquid, semisolid and solid lipid-based drug delivery systems.  Fifth World Conference on Physicochemical Methods in Drug Discovery and Development, Zhuhai, China. August 23-26, 2016.
  • Enabling pharmaceutical technologies for drug delivery systems. KEYNOTE PRESENTATION in the Annual Scholarship Meeting of the New Jersey Association of Pharmaceutical Science and Technology (NJPhAST), New Jersey. May 19, 2016.
  • Technological Advances in Pharmaceutical Research. ST. JOHN’S UNIVERSITY PUBLIC LECTURE on Novel Drug Delivery Systems to Increase Benefits by Better Therapy. St. John’s University, Queens, New York. (Lecture open to the university community and New York City area public). April 13, 2016. 
  • Successful transition from industry to academia. Professional Development Mini-symposium: AAPS Annual Meeting, Orlando, Florida. October 25-29, 2015.
  • A systematic approach to development of SEDDS: Phase diagram and cytotoxicity assessment. AAPS Outstanding Award In Lipid-based Drug Delivery Lecture.  AAPS Annual Meeting, Orlando, Florida. October 25-29, 2015.
  • Structure of pharmaceutical research and different paradigms of drug and formulation development in the pharmaceutical industry.  Fourth World Conference on Physicochemical Methods in Drug Discovery and Development, Red Island, Croatia. September 21-24, 2015
  • Biopharmaceutics risk assessment roadmap (BioRAM): Optimization of clinical drug product performance.  Fourth World Conference on Physicochemical Methods in Drug Discovery and Development, Red Island, Croatia. September 21-24, 2015.
  • Enabling technologies for bioavailability enhancement and dosage form development of poorly water-soluble drugs.  Fourth World Conference on Physicochemical Methods in Drug Discovery and Development, Red Island, Croatia. September 21-24, 2015.
  • Practical strategies for the development of lipid-based drug delivery systems for poorly water-soluble drugs.  Fourth World Conference on Physicochemical Methods in Drug Discovery and Development, Red Island, Croatia. September 21-24, 2015.
  • Physicochemical considerations in selecting polymers for preparation of solid dispersion by melt extrusion. 6th Symposium on Solubility Enhancement Utilizing Pharmaceutical Melt Extrusion and Spray Drying Techniques, organized by Evonik Industries, Piscataway, New Jersey. May 7, 2015.
  • Navigating BioRAM for maintenance of target exposure. University of Wisconsin Workshop on “Navigating the Biopharmaceutics Risk Assessment Road Map (BioRAM):  Therapy-Driven QTPP Strategies for Clinically Relevant-Specification Setting”, USP Conference Center, Rockville, Maryland. April 28-29, 2015.
  • The future of tableting technology: Impact of hot-melt granulation using twin-screw extruders. The AAPS Research Achievement Award Lecture, AAPS-MSE Section Business Meeting, San Diego, California. November 4, 2014.  
  • Implications of solidifying self-emulsifying drug delivery systems. AAPS Workshop on Improving Oral Bioavailability by Lipid-based Delivery Approaches, AAPS Annual Meeting, San Diego, California. November 1-2, 2014.
  • Preformulation considerations in development of amorphous solid dispersion by hot-melt extrusion. Conference on ‘Advances in Drug Delivery: Optimal Bioavailability and Controlled Release Solutions for Improved Outcomes’, Catalent Advanced Drug Delivery Institute, Somerset, New Jersey. September 10, 2014.
  • The future of pharmaceutical research in the USA. KEYNOTE PRESENTATION. The 33rd Annual Conference of the Graduate Research Association in Pharmacy, St. John’s University, Queens, New York. June 5-7, 2014.
  • Practical considerations in the development of solid dispersion by hot-melt extrusion. The 2nd David Grant Symposium, University of Minnesota, Minneapolis, Minnesota. May 21-22, 2014.
  • Enabling technologies for dosage form development of poorly water-soluble drugs. University of Kentucky, Lexington, Kentucky. May 9, 2914.
     

  • St. John’s University Medal for Outstanding Achievement, 2019,St. John’s University
  • College of Pharmacy and Health Sciences, Distinguished Alumni Award, 2018, St. John's University. 
  • Faculty Recognition Award for Outstanding Teaching and Services, 2009-2018, St. John’s University(received consecutively 10 times from 2009 to 2018).

  • Distinguished Alumni Award, 2018, College of Pharmacy and Health Sciences, St. John’s University

  • Ralph Shangraw Memorial Award, 2016 International Pharmaceutical Excipients Council (IPEC) (highest scientific recognition by the industry association)

  • Lipid-Based Drug Delivery Outstanding Research Award, 2015, American Association of Pharmaceutical Scientists (AAPS)

  • Research Achievement Award in Manufacturing Science and Engineering (MSE), 2014, American Association of Pharmaceutical Scientists (AAPS)

  • Research Achievement Award in Formulation Design and Development (FDD), 2010, American Association of Pharmaceutical Scientists (AAPS)

  • Fellow, 2006, American Pharmacists’ Association (APhA)

  • Novartis Leading Scientist, 2005, Novartis Pharmaceuticals Corp., 2005(top recognition by Novartis for extraordinary scientific achievement)

  • Member, Editorial Advisory Board, 2005-present, Journal of Pharmaceutical Sciences

  • Fellow, 2004, American Association of Indian Pharmaceutical Scientists (AAiPS)

  • Distinguished Scientist Award, 2004, American Association of Indian Pharmaceutical Association (AAiPS)

  • Chair, Pharmaceutics and Drug Delivery Section, 2001, American Association of Pharmaceutical Scientists (AAPS) (led the largest section of AAPS with 5,600 primary and secondary members)

  • Fellow, 2001, International Union of Pure and Applied Chemistry (IUPAC)

  • Fellow, 1998, American Association of Pharmaceutical Scientists (AAPS)

  • President’s Award, 1996-98, Bristol-Myers Squibb (BMS) Pharmaceutical Research Institute (received unprecedented 3 times for outstanding contribution to drug development at BMS)

  • Productivity for Growth Award for Exemplary Leadership, 1995, Bristol-Myers Squibb Corp. (a corporate level award for accelerating drug development at BMS)

  • Chair, Preformulation Focus Group, 1994-1996, American Association of Pharmaceutical Scientists (AAPS)

  • Top Ten Publication of the Decade of 1990s, Journal of Pharmaceutical Sciences [one of Serajuddin’s paper (JPharmSci 1999, 88:1058-1066) was recognized as top ten paper published in the journal in the decade of 1990s. It was part of a commemorative issue. The paper has to date been cited over 1800 times)